Compare Amphastar Pharmaceuticals Inc (AMPH) vs Roundhill NVDA WeeklyPay ETF (NVDW) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

NVDW trades at $37.56, up 4.71% today, but technical indicators signal bearish momentum with selling pressure outweighing buying signals. The stock faces resistance near $38-39 while finding support around $35-33. Recent dividend activity shows frequent but variable payouts, with Seeking Alpha noting the ETF's quasi-synthetic leveraged position in Nvidia generates fluctuating income streams.

The outlook remains cautious due to technical bearish signals and payout volatility. Investment opportunity exists for income-focused investors seeking Nvidia exposure, but risks include dependency on NVDA performance and significant weekly dividend fluctuations that challenge yield predictability.